Body Is Porridge: Understanding Somatic Symptom Disorder and Maladaptive Illness Beliefs in Perceived Bodily States

Somatic Symptom Disorder (SSD) is a mental health condition in which an individual experiences one or more distressing physical symptoms—such as pain, fatigue, gastrointestinal discomfort, or sensations described in highly vivid, sometimes metaphorical ways (e.g., “body is porridge”)—and responds with excessive concern, persistent rumination, and maladaptive health-related behaviors. The key clinical feature is not the presence of a symptom alone, but the pattern of thinking, emotion, and behavior that sustains impairment even when medical explanations are absent, limited, or insufficient. SSD commonly emerges after stress, illness, injury, or changes in bodily function, and may be maintained by attentional amplification of bodily signals, catastrophic interpretation, and avoidance of normal activities.

At the mechanistic level, SSD is understood through a biopsychosocial framework. Biological factors include heightened interoceptive sensitivity (increased attention to internal bodily sensations) and alterations in stress physiology, including dysregulated hypothalamic–pituitary–adrenal (HPA) axis activity. These changes can influence pain modulation, fatigue perception, and autonomic arousal. Psychological processes include selective attention to bodily cues, hypervigilance, and cognitive distortions such as catastrophizing (“this sensation means something is seriously wrong”). Emotional mechanisms involve fear, shame, or helplessness, which increase vigilance and deepen symptom focus. Social factors include reinforcement from repeated reassurance seeking, frequent medical visits without symptom resolution, and interpersonal reinforcement of the sick role.

Interoception research describes how the brain continuously integrates signals from the body to produce a coherent sense of internal state. In SSD, this integration process can become biased: ordinary sensations are perceived as intense, threatening, or abnormal. A person may interpret vague discomfort through an elaborate personal narrative. Metaphorical descriptions can reflect that narrative—rather than literal physiology, they may express uncertainty, disorganization in sensation interpretation, and distress. Clinicians should approach such language respectfully while translating it into functional targets: symptom intensity, functional impairment, and health-related behaviors.

DSM-5-TR criteria emphasize disproportionate and persistent thoughts about seriousness, repeatedly high levels of anxiety about health, and significant time devoted to symptoms or health concerns. Patients may also demonstrate maladaptive coping, including avoidance of activity due to fear of symptom worsening, prolonged checking behaviors (e.g., monitoring bodily sensations), and excessive reassurance seeking. Importantly, SSD does not require that symptoms be medically unexplained; it can coexist with genuine medical conditions. However, the psychological response to symptoms is what drives chronic impairment.

A common clinical pitfall is assuming that because symptoms are “subjective,” the distress is not real. SSD is real and distressing. The symptoms are genuine experiences, and the resulting disability can be substantial. Differentiating SSD from related conditions is crucial. Illness Anxiety Disorder (hypochondriasis) features a preoccupation with having or acquiring a serious illness with minimal or no somatic symptoms; SSD features prominent symptoms with persistent distress. Somatic complaints must also be distinguished from psychotic disorders, where beliefs about the body may be fixed and delusional, and from mood disorders, where bodily symptoms may occur in the context of depression.

Evaluation typically includes a structured clinical interview to map symptom chronology, triggers, cognitive appraisals, coping patterns, and functional outcomes. Baseline medical assessment is recommended to rule out urgent pathology and to establish whether any comorbid conditions exist. After appropriate evaluation, management prioritizes reducing maladaptive health behaviors and reshaping the interpretation of bodily sensations. Evidence-based treatments include cognitive behavioral therapy (CBT) tailored to SSD, focusing on cognitive restructuring, interoceptive exposure, reduction of safety behaviors, and addressing rumination and reassurance cycles.

Pharmacotherapy may be considered when anxiety or comorbid depression is present. Selective serotonin reuptake inhibitors (SSRIs) are frequently used in anxiety- and depression-spectrum presentations, though medication is adjunctive rather than curative for the core syndrome. Patient education is foundational: clinicians should validate symptoms, avoid invalidation, and explain the role of attention, stress, and threat interpretation in amplifying symptoms.

Prognosis is often better when care is consistent and coordinated, with limited repeated investigations unless clinically indicated. Longitudinal improvement can occur as patients learn to interpret bodily sensations as non-catastrophic, engage in valued activity, and reduce health-related compulsions. Addressing underlying stressors, trauma, and sleep disruption can further reduce symptom persistence.

If someone describes vivid bodily experiences such as “my body is porridge” alongside high distress, clinicians should assess whether the language reflects interoceptive alarm and catastrophic interpretation, how it affects daily functioning, and whether there is a cycle of fear–rumination–avoidance. This approach supports safe, compassionate care while targeting the psychological mechanisms that maintain SSD and related somatic symptom presentations. Source: [@amanya_onesmas] (X/Twitter).